Rapid Nutrition Announces Issue of Convertible Instruments

May 7, 2018



Switzerland – In an effort to increase the free float of its Shares (GB00BLG2TX24) listed on SIX Swiss Exchange, Rapid Nutrition has successfully placed Convertible Instruments with new investors and management*. Once converted in full, the Convertible Instruments will increase the current share capital by 35% to a total number of Shares 31,388,396 outstanding Shares. The funds of GBP £1,055,875 raised by Rapid Nutrition through this issue of Convertible Instruments will be used to reduce debt and to finance the further growth of the Company.


Commenting on recent investment, Simon St Ledger, Chairman, said "In light of the recent joint venture agreement with the NYSE listed General Nutrition Corporation ("GNC"), the funding facilitates our ambitious growth plans over the next 12 months.



About Rapid Nutrition

Rapid Nutrition is a natural healthcare company focused on the research, development and production of a range of life science products. The company was established based on its successful and proven weight loss supplement range which is exported worldwide and now offers consumers a growing range of health and well-being solutions to meet existing and emerging societal health concerns, as well as a providing number of wider services to the life sciences industry.


For more information, please visit http://rnplc.com


or contact Investor Relations: info@rnplc.com




*Disclosure: Director/PDMR Shareholding - Simon St Ledger, Chief-Executive Officer has purchased 2,448,458 Ordinary Shares at a price of £0.184 per Ordinary Share (the "Purchase"). Following the Purchase, Simon St Ledger now holds a total of 2,448,458 Ordinary Shares representing approximately 10.5% voting rights of the issued share capital of the Company.This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Disclaimer:This communication expressly or implicitly contains certain forward-looking statements concerning Rapid Nutrition PLC and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of the Rapid Nutrition group to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Rapid Nutrition PLC is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise. This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning of article 652a or article 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange. This media information is not being issued in countries where the public dissemination of the information contained herein may be restricted or prohibited by law. In particular, this media information is not being issue in the United States of America and should not be distributed to U.S. persons or publications with a general circulation in the United States. Any non-compliance with such restrictions may result in an infringement of U.S. Securities Laws. In particular, the securities of Rapid Nutrition PLC have not been registered under the U.S. Securities laws and may not be offered, sold or delivered within the United States or to U.S. persons absent the registration under or an applicable exemption from the registration requirements of the U.S. Securities laws. This information is for distribution in the United Kingdom only to: persons who (i) are outside the United Kingdom; (ii) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (Order); (iii) are persons falling within Article 48(2) of the Order (certified high net worth individuals); (iv) are persons falling within Article 49(2) of the Order (high net worth companies, unincorporated associations, etc.); (v) are persons falling within article 50(1) of the Order (sophisticated investors); (vi) are persons falling within article 50A(1) of the Order (self-certified sophisticated investors); (vii) are persons falling within article 51 of the Order (associations of high net worth or sophisticated investors); or (viii) are persons to whom it may otherwise lawfully be communicated (all such persons together being Relevant Persons). This media information is only available to Relevant Persons and persons other than Relevant Persons must not act or rely on it. This media information may not be provided in Australia other than to select investors ("Exempt Investors") who are able to demonstrate that they (a) fall within one or more of the categories of investors under section 708 of the Australian Corporations Act to whom an offer may be made without disclosure under Part 6D.2 of the Australian Corporations Act and (b) are "wholesale clients" for the purpose of section 761G of the Australian Corporations Act.

Please reload